Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

The search for a cure

Nail Fungus Drug Might Help Against HIV: Study

Editor's pick
WebMD
25 September 2013
New & experimental HIV treatments

CHMP recommends that Vitekta (elvitegravir) should be granted marketing authorisation

Editor's pick
European Medicines Agency
25 September 2013
Pharmaceutical industry

Seven Ways to Speed up the HIV Treatment Pipeline

Editor's pick
Positive Lite
24 September 2013
New & experimental HIV treatments

Good safety profile with long-acting integrase inhibitor, GSK744

Editor's pick
NATAP
19 September 2013
How HIV works

Gene discovery could lead to new types of HIV treatments

Editor's pick
Reuters
19 September 2013
New & experimental HIV treatments

Will Germany Squelch Gilead Hopes For Its Stribild AIDS Drug?

Editor's pick
Pharmalot
19 September 2013
Treatment guidelines

NHS England approve Stribild (Quad)

Editor's pick
HIV i-Base
12 September 2013
New & experimental HIV treatments

Drug design success propels efforts to fight HIV with a combination of 2 FDA-approved drugs

Editor's pick
HIV / AIDS News From Medical News Today
4 September 2013
Pharmaceutical industry

ViiV goes for gold: US premium pricing may threaten dolutegravir use in Europe

Editor's pick
HIV i-Base
19 August 2013
New & experimental HIV treatments

Neutron studies of HIV inhibitors reveal new areas for improvement

Editor's pick
Science Codex
15 August 2013
New & experimental HIV treatments

ViiV's newly minted HIV fighter Tivicay to cost $14K per year

Editor's pick
Fierce Pharma
14 August 2013
Access to healthcare

As US FDA approves promising new HIV drug dolutegravir, MSF asks when people in developing countries will have access

Editor's pick
MSF
13 August 2013
New & experimental HIV treatments

FDA approves new drug to treat HIV infection

Editor's pick
FDA
13 August 2013
Access to healthcare

HIV Survivors Seek Drug Advances as FDA Eases Approvals

Editor's pick
Bloomberg
12 August 2013
New & experimental HIV treatments

Fight AIDS with your smartphone

Editor's pick
CNN Money
8 August 2013
New & experimental HIV treatments

Plant-based compound may inhibit HIV

Editor's pick
Eurekalert Medicine & Health
30 July 2013
HIV treatment for children & young people

Low-Dose Drug Combo Safe in Kids with HIV

Editor's pick
Medpagetoday.com
8 July 2013
Resistance

Licensing agreement for development of diagnostic tests for HIV drug resistance

Editor's pick
University Hospitals Case Medical Center
3 July 2013
Access to healthcare

2013 Pipeline Report calls on leaders to get the best HIV, hepatitis C virus (HCV), and tuberculosis drugs, diagnostics, and vaccines to the most people as quickly as possible

Editor's pick
Treatment Action Group
30 June 2013
New & experimental HIV treatments

Tenofovir Alafenamide Fumarate (TAF) Sign-On Letter to Gilead

Editor's pick
Treatment Action Group
17 June 2013
New & experimental HIV treatments

New FDA Guidance for Industry: Developing Antiretroviral Drugs for Treatment

Editor's pick
US Food and Drug Administration
11 June 2013
New & experimental HIV treatments

European Commission Approves Stribild®, a New Single Tablet Regimen for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
28 May 2013
New & experimental HIV treatments

Nanoparticles May Transport HIV Meds to the Brain

Editor's pick
AIDSMeds
16 May 2013
The search for a cure

UPDATE: Sangamo Highlights Encouraging Preliminary Anti-Viral HIV Data

Editor's pick
Benzinga
15 May 2013